T&R Biofab Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.12%

T&R Biofab Co. Ltd (246710) has an Asset Resilience Ratio of 0.12% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩100.00 Million

≈ $67.77K USD Cash + Short-term Investments

Total Assets

₩83.86 Billion

≈ $56.83 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how T&R Biofab Co. Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of T&R Biofab Co. Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down T&R Biofab Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see T&R Biofab Co. Ltd (246710) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩100.00 Million	0.12%
Total Liquid Assets	₩100.00 Million	0.12%

Asset Resilience Insights

Limited Liquidity: T&R Biofab Co. Ltd maintains only 0.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

T&R Biofab Co. Ltd Industry Peers by Asset Resilience Ratio

Compare T&R Biofab Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for T&R Biofab Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for T&R Biofab Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.55%	₩17.28 Billion ≈ $11.71 Million	₩98.45 Billion ≈ $66.72 Million	-34.30pp
2023-12-31	51.84%	₩51.75 Billion ≈ $35.07 Million	₩99.82 Billion ≈ $67.64 Million	-1.39pp
2022-12-31	53.23%	₩40.42 Billion ≈ $27.39 Million	₩75.94 Billion ≈ $51.46 Million	-17.50pp
2021-12-31	70.73%	₩58.17 Billion ≈ $39.42 Million	₩82.23 Billion ≈ $55.73 Million	-5.30pp
2020-12-31	76.03%	₩36.88 Billion ≈ $24.99 Million	₩48.51 Billion ≈ $32.87 Million	-4.17pp
2019-12-31	80.20%	₩21.72 Billion ≈ $14.72 Million	₩27.09 Billion ≈ $18.36 Million	-11.94pp
2018-12-31	92.13%	₩28.66 Billion ≈ $19.42 Million	₩31.10 Billion ≈ $21.08 Million	+9.69pp
2017-12-31	82.44%	₩7.80 Billion ≈ $5.29 Million	₩9.47 Billion ≈ $6.42 Million	-1.57pp
2016-12-31	84.01%	₩8.06 Billion ≈ $5.46 Million	₩9.59 Billion ≈ $6.50 Million	--

pp = percentage points

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices

Market Cap

$55.92 Million

₩82.52 Billion KRW

Market Cap Rank

#21419 Global

#1224 in Korea

Share Price

₩2705.00

Change (1 day)

-9.83%

52-Week Range

₩1194.00 - ₩4535.00

All Time High

₩44150.00